ARTICLE | Company News
Neurex other research news
June 12, 1995 7:00 AM UTC
The Menlo Park, Calif., company received a $100,000 Phase I SBIR from the National Institute of Neurological Diseases and Stroke to study the molecular mechanisms underlying neuronal apoptosis. ...